Brief, Performance-Based Cognitive Screening in Youth Aged 12–25: A Systematic Review
Journal of the International Neuropsychological Society
Bryce, S. D., Bowden, S. C., et al. (2021).
Journal of the International Neuropsychological Society, 27(8), 835-854.
This systematic review investigates the accuracy of cognitive screenings for individuals aged 12-25.
National Health and Medical Research Council (Australia)
From database inception to December 3, 2018
Original, peer-reviewed research articles
20
The MoCA demonstrated good classification accuracy for detecting cognitive impairment in young people with congenital heart disease. The pediatric ANAM demonstrated good to poor/very poor accuracy in young people with systemic erythematosus lupus. DIVERGT, MoCA, BNBC, and pedANAM all showed sensitivity ranges grater than 0.80 and specificity ranges greater 0.60 in specific groups of young people (e.g., oncology for the DIVERGENT, individuals with multiple sclerosis for the BNBC). The Figural Memory task of the Neurocog FX had a positive likelihood ratio above 10 when compared to the reference standard. While specificity was high (.57–.99), the sensitivity was lower (.14–.76) for this measure.
